Skip to main content

Table 1 Correlation between NLK expression and clinicopathological parameters of PCa patients

From: Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer

No

NLK protein expression (%)

p

High

Low

Group

    

 BPH

50

31 (62.0)

19 (38.0)

.003

 PCa

118

44 (37.3)

74 (62.7)

 

Age (year)

    

 <70

45

14 (31.1)

31 (68.9)

.276

 ≥70

73

30 (41.1)

43 (58.9)

 

Gleason score

    

 4–6

42

28 (66.7)

14 (33.3)

<.001

 7

20

7 (35.0)

13 (65.0)

 

 8–10

56

9 (16.1)

47 (83.9)

 

CS (TNM)

    

T stage

    

 T1-T2

56

28 (50.0)

28 (50.0)

.007

 T3-T4

62

16 (25.8)

46 (74.2)

 

N stage

    

 N0

90

39 (43.3)

51 (56.7)

.015

 N1

28

5 (17.9)

23 (82.1)

 

M stage

    

 M0

94

39 (41.5)

55 (58.5)

.065

 M1 (bone)

24

5 (20.8)

19 (79.2)

 

Nurr1 expression

    

 High

84

18 (21.4)

66 (78.6)

<.001

 Low

34

26 (76.5)

8 (23.5)

 
  1. Statistical analyses were performed by the Pearson χ 2 test, p < 0.05 was considered significant